1. "Drug Administration Law of the People's Republic of China"

The Drug Administration Law of the People's Republic of China takes drug supervision and management as its core content and discusses in depth Drug review and quality inspection, medical device supervision and management, drug production and operation management, drug use and safety supervision and management, hospital pharmacy standardization management, drug audit management, drug centralized bidding and procurement management, have scientific guiding significance for the medical and health undertakings and development .

Adopted at the seventh meeting of the Standing Committee of the Sixth National People's Congress on September 20, 1984, and came into effect on July 1, 1985. The current version was revised at the 14th meeting of the Standing Committee of the 12th National People's Congress on April 24, 2015.

On October 22, 2018, the draft amendment to the Drug Administration Law was submitted to the Standing Committee of the National People's Congress for review. The draft will comprehensively increase penalties for the production and sale of counterfeit and substandard drugs.

2. "Chinese Pharmacopoeia"

(referred to as "Chinese Pharmacopoeia") is a book published by China Medical Science and Technology Press on June 5, 2015. It is created by the National Pharmacopoeia Committee.

The "Chinese Pharmacopoeia" is published in four parts: the first part contains medicinal materials and pieces, vegetable oils and extracts, prescription preparations and single-flavor preparations; the second part contains chemicals, antibiotics, and biochemical drugs and radioactive pharmaceuticals, etc.; Part Three contains biological products; Part Four contains general principles, including: general principles for preparations, testing methods, guiding principles, general principles related to reference materials and test solutions, pharmaceutical excipients, etc.

3. "Measures for the Management of Toxic Drugs for Medical Use"

In order to strengthen the management of toxic drugs for medical use and prevent the occurrence of poisoning or death accidents, according to the "Regulations of the People's Republic of China and the The provisions of the National Drug Administration Law are formulated. Passed by the 25th Executive Meeting of the State Council on November 15, 1988, it was promulgated and implemented by the State Council on December 27, 1988.

4. "Regulations on the Management of Precursor Chemicals"

It is a regulation on the management of precursor chemicals. It was promulgated by the State Council of the People's Republic of China on August 26, 2005 and came into effect on November 1, 2005. ***There are eight chapters and forty-five articles.

Amended in accordance with Article 15 of the State Council Order No. 653 "Decision of the State Council on Amending Certain Administrative Regulations" promulgated on July 29, 2014.

Amended in accordance with Article 46 of the State Council Order No. 666 "Decision of the State Council on Amending Certain Administrative Regulations" promulgated on February 6, 2016.

Amended in accordance with Article 6 of the State Council Order No. 703 "Decision of the State Council on Amending Certain Administrative Regulations" published on September 18, 2018.

5. "Regulations on the Protection and Management of Wild Medicinal Resources"

The Regulations on the Protection and Management of Wild Medicinal Resources are my country's administrative regulations for the protection and management of medicinal wild animal and plant resources. It was promulgated by the State Council on October 30, 1987 and came into effect on December 1, 1987.

my country’s wild medicinal resources are extremely rich, but the situation of indiscriminate harvesting and hunting is very serious.

In order to protect and rationally utilize wild medicinal material resources, the "Regulations on the Protection and Management of Wild Medicinal Material Resources" stipulates the management principles of wild medicinal material resources, national key protected wild medicinal material species, hunting rules for wild medicinal materials, and wild medicinal material resources. Provisions are made on the establishment and management of protected areas, the management and export of wild medicinal materials, the prices, grade standards, rewards and penalties of wild medicinal materials.

The regulations declare that the state will implement the principle of combining protection and hunting of wild medicinal materials, and create conditions for artificial cultivation.

Baidu Encyclopedia - Measures for the Administration of Toxic Drugs for Medical Use

Baidu Encyclopedia - The People's Republic of China and the Pharmacopoeia

Baidu Encyclopedia - The People's Republic of China and the Pharmacopoeia National Drug Administration Law